Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02444195 · ClinicalTrials.gov registry record · NA

Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

A NA study of Ovarian Neoplasms and Fallopian Tube Neoplasms, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT02444195 is a NA study of Ovarian Neoplasms and Fallopian Tube Neoplasms that has completed, run by University of Michigan. The registered enrollment target is 130 participants, below the 364-participant average among 38 other Ovarian Neoplasms trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02444195, a NA study of Ovarian Neoplasms and Fallopian Tube Neoplasms, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of self-administered perioperative guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing surgical management for a presumed cancer diagnosis.

Interventions

  • BEHAVIORAL Guided Imagery With Audio Media

Study Locations (1)

Michigan

  • University of Michigan Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2015-04
Est. Completion 2016-05-01
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02444195

The ClinicalTrials.gov registry entry for NCT02444195 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 364-participant average among 38 other Ovarian Neoplasms trials with a reported enrollment target (64% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Ovarian Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Guided Imagery With Audio Media is the first listed.

NCT02444195 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02444195 about?

NCT02444195 is a clinical study titled "Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients". The purpose of this study is to evaluate the effectiveness of self-administered perioperative guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing surgical management for a presumed cancer diagnosis.

What is the current status of trial NCT02444195?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2015-04. Estimated completion is 2016-05-01.

What conditions does trial NCT02444195 study?

This clinical trial studies the following conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms, Urogenital Neoplasms, Uterine Cervical Neoplasms, Uterine Neoplasms.

What interventions are being tested in trial NCT02444195?

The interventions under investigation include: Guided Imagery With Audio Media (BEHAVIORAL).

Who is sponsoring clinical trial NCT02444195?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02444195 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ovarian Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.